chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red rash appeared on left arm below where the shot was adminstered four days after getting shot; welts appeared on left arm below where the shot was adminstered four days after getting shot; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 13:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included goiter-Thyroid. The patient had no known allergies. Concomitant medications included cimicifuga racemosa (BLACK COHOSH) 540mg, cyanocobalamin (VITAMIN B12) 1000mcg, and colecalciferol (VITAMIN D3) 25mcg from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 13:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 08:00 the patient experienced red rash and welts appeared on left arm below where the shot was administered. Four days after getting shot. Patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events red rash, welts was not recovered at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Pt had 2 cm red knot on right thigh, local reaction.  No fever.
(L) shoulder pain radiating to (L) elbow. Treatment ongoing with orthopaedics for adhesive capsulitis. Treated with prednisone, steroid injection, physical therapy.
26 patients received the vaccine prepared without the final inverting after diluent added; 26 patients received the vaccine prepared without the final inverting after diluent added; This case is considered as invalid as there is no indication that the patient experienced an event under suspect BNT162B2.  This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar events for 26 patients. This is for 5th of 26 report. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunisation. The patient medical history and the concomitant medications were not reported. The pharmacist wanted information about needing to revaccinate patients with the covid 19 vaccine in the instance where all preparation steps were followed except gently inverting the vial 10 times after adding the diluent. The vial color and appearance was off white with no particulate matter. 26 patients received the vaccine prepared without the final inverting after diluent added. The outcome was unknown.    Follow-up (08Feb2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.  Follow-up (09Feb2021): This is a follow-up spontaneous report received from a contactable Pharmacist. This Pharmacist reported in response to HCP letter sent that included: Phone Out 11:40 AM EST, 2nd attempt by phone to HCP to obtain mailing information. Phone answered by pharmacist who stated he never reported any adverse event and that the event in the report was all a confusion and everything is fine. HCP did not provide fax number or mailing address and does not wish to be contacted any further.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020521662 same reporter/drug/event, different patient
When patient received the vaccines, within 24 hours he ran a high fever, he broke out into a severe rash that covered his entire body that lasted several days. We took him to the ER. Temp 103-104.
pt recvd vax; devel rash 1 1/2 wks later; tx in er; NMH p/ 1 wk of nov94 (thanksgiving);
allergic reaction; itching throat, mouth, lips; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program. A patient of an unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date in Feb2021 as single dose for COVID-19 immunization. The patient's medical history included asthma (went home where patient had to continue BENEDRYL and asthma medication for the next). There were no concomitant medications reported. On an unspecified date in Feb2021, the patient received first COVID shot and had an allergic reaction. Within in 10 minutes of receiving the vaccine, the patient experienced itching throat, mouth, and lips. Treatment was received for the events with a shot of BENEDRYL, went home where patient had to continue BENEDRYL for the next two days. Patient was advised by allergist not to get the second shot. Would like to know when patient should try a COVID vaccine again. Outcome of the events was reported as unknown.  Information about batch/lot number has been requested.
Vaccine administered into L deltoid. Almost immediately, arm was itchy. itchiness spread throughout entire body & breathing became slightly difficult. Benedryl & epi pen administered.
Patient was administered 0.5ml instead of 0.25ml for booster 3rd dosage, Patient called and denies any problems since receeving the vaccine. Letter sent to patient informing of dosage given
LOW GRADE FEVER. PT DID SEEK MEDICAL ATTENTION. PT WAS PRESCRIBED ANTIBIOTICS. FEVER PERSISTED DESPITE TREATMENT WITH ANTIBIOTICS DURATION 10 DAYS.
This case was received on 27 January 2010 from a healthcare professional. A 62 year old female patient received an injection (site and route not reported) of Influenza vaccine (Manufacturer unknown, lot not reported) on 23 January 2010. "That night" she experienced blood sugar levels of 348. The patient stated that on 19 January 2010 her blood sugar level was 320 and on an unspecified date her blood sugar level was 73. The patient's concomitant medication was LANTUS SOLOSTAR once a day (sliding scale) for diabetes mellitus type 2. She had a history of a foot operation on 28 October 2009, which the patient stated was for arthritis on the top of her foot. It was not reported if the patient had any illness at the time of the vaccination. The outcome of the patient's elevated blood sugars was not reported. Follow-up information was received on 22 March 2010 from the patient, who stated the event of elevated blood sugars was "a problem with the LANTUS, not the flu shot". Follow-up information was received on 31 March 2010 from the patient. On 23 January 2010, the patient received H1N1, lot number UP057AA. She had a ten year history of diabetes. She reported that her doctor attributed her blood sugar elevations to her recent foot surgery and subsequent infection. The start and stop dates for the blood sugar elevations were unknown. The patient stated she had recovered and had not had any additional problems controlling her blood sugar levels since 23 January 2010. She stated she did not have an adverse event following administration of the H1N1 vaccine. It should be noted that the information received in the initial version of this case on 27 January 2010 was provided by the patient and not a health care professional. The case is not medically confirmed. Documents held by sender: None.
Patient started off with a simple cold, never sick before receiving this vaccine. Slowly her cold started getting worse. I kept taking her to doctors who kept saying she is fine. Until doctor  finally confirmed what I knew was wrong with my baby. Bronchitis. Almost pneumonia.
Severe arm pain, headache, body aches, fatigue, fever, nausea, sore throat, basically felt like I had covid again
INITIALLY, I EXPERIENCED DIZZYNESS AND FAINTNESS. GRADUALLY, I EXPERIENCE, TIRENESS, MUSCLE ACHE AND NASEAU. THESE SYMPTONS ARE CONSTANT AT THE MOMENT.
Vaccine shot received 4pm Sunday, Monday morning  woke up lethargic, fever began to develop around 8:30am and tingling began in hands that hurt to the touch.  At noon took a benadryl and ibuprophen when fever reached 101.6.  Tingling sensation continued on and off through the day in waves in my arms, legs, stomach and middle part of my spine.  Lower back pain developed.  Severe headache occurred around 6pm and pain in liver.  Woke up Tuesday without incident; no fever, no more tingling or pain.  However, I have a swollen lymph node in my right collar bone and mild pink streak in shoulder on my right arm near the injection site.
Redness, soreness, warmth, induration, and tingling sensation "radiating down left arm". Body temp @ office visit on 9/26/19 was 99.3 degrees F (forehead).
patient fainted.  pale. After seeing her arm bleed after the immunization.  Bleeding was stopped with cotton ball and bandaid. Had patient drink water, had parents fan the patient to keep her cool, had her stay seated,  breathing exercise.  Called family about an hour later and father said she is feeling fine.
Night sweats, 3 nights Unable to do anything except get to the bathroom Pulse rate extremely high...4 days then went to the hospital. Screwed up my thyroid
I had told the nurse I was dizzy beforehand so she wanted me to sit there to keep an eye on me. I did get dizzy but not as bad as the first dose, but more of a light headed feeling versus everything moving around me, but it could be that I was sitting down and not standing. The light headedness stuck with me most of the day, and that afternoon about 3-4 PM my legs and arms were really achy and by the next morning when I woke up my whole body hurt and felt like I had a really bad flu. The blankets on my bed even hurt my legs so I took an Aleve again and it helped but I would say it didn't completely go away for another 24 hours. It wasn't until mid day Sunday I actually felt okay again. I could walk but my legs felt heavy. By the time I went to bed on Sunday it seemed okay, and on Monday morning they were fine. I did run a low grade fever around 100 starting 24 hours after vaccine, and that lasted for maybe 12 hours and I didn't have it by the time I went to bed that night.
Patient has had a dull pain in the arm since the vaccine administration.  Starting on 7/27 the pain increased.  When the injection site is pressed there is shooting, jabbing pain.  Patient says that it feels like it is nerve related, pain at the back of his arm, through his elbow, and into his forearm.  Certain positions cause more pain.
Pfizer-BioNTech COVID-19Vaccine  Side effects of chills, low-grade fever, myalgia began at 6:00 PM on the evening of receiving a vaccine. Side effects were subjectively worse than after first dose (12/22/2020). Side effects continued the following day and night and resolved two days later on the morning of 1/14/2021.
A patient's aunt reported that her nephew received three separate doses of Acel-Imune and Hib-Titer and possibly one dose of Rota Shield between December, 1998 and April, 1999 and developed autism. As of 04/05/01, no further info was available. MANUFACTURER"S COMMENT: The lot number for the first dose of Hib-Titer was reported as 48020; however, this is not a valid Lederle lot number. The reporter also indicated that the lot number for Rota shield was M235RA: however, this is not a valid Wyeth lot number. This lot number (M235RA) is a valid Lederle lot number.
Pt waited 10 out of 15 mins started feeling tightness in the throat. proceeded with the appropriate treatment. Pt received epinephrine 0.3Mg IM. Pt received Benadryl 25Mg PO. Pt transferred to ER via EMS.
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Lymph Node Swelling-Mild, Additional Details: NOTISABLE SWELLING OF THE LEFT ARM AND SLIGHT REDNESS,  NO MOTION DIFFICULTIES.
Fever 102.1; Chills; achy; This is a spontaneous report from two contactable healthcare professionals. A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686) at the age of 61 years, intramuscular on the left arm on 27Jan2021 16:15 at a single dose for COVID-19 immunization. Medical history included high blood pressure, COVID-19 and allergies to quinolones. The patient's concomitant medications were not reported. The patient is not pregnant. The patient previously took celecoxib (CELEBREX) and experienced allergies. The patient experienced fever 102.1, chills and achy on 28Jan2021 08:00. The patient did not received any treatment for the events. The outcome of the events was not recovered.
Patient administered Moderna, as third dose. Patient denies ever receiving any covid-19 vaccine, however, two doses documented in state registry from . RN called  to confirm vaccine administration. No adverse reaction noted during the 15 min post vaccination observation period.
Patient stated her arm became increasingly sore post immunization and by the evening of 10/13/2018 she could barely move her arm. She stated her arm was swollen and sore and she could barely move it. The swelling is primarily located in the axillary and neck region. Patient went to the emergency room and was told the injection hit a nerve in her arm. Patient was given prednisone and nausea medication in the emergency room. She was prescribed a muscle relaxer and steroid dose pack that she is going to start on 10/15/18. She will follow up with her primary care physician.
He got his vaccine, he had a low grade temperature and chills and shakes.  Then his whole body had aches and pains, every joint in his body.  He had a hip replacement and this activated the pain.  Wife took him to the ER a couple of times and said that he had a virus.  He is now admitted due to heart racing, he had an echocardiogram and all of his lab work is elevated.  His heart rate is normally 60 and it was 118-120 and admitted for that.    He was admitted to the hospital on Sunday and they are running tests, and is still in the hospital.
This case was reported by a physician via sales representative and described the occurrence of flush all over in a 4-month-old subject of unspecified gender who was vaccinated with PEDIARIX, (GlaxoSmithKline), HIB, ROTATEQ (non-gsk), and PREVNAR.  On an unspecified date, the subject received 2nd dose of PEDIARIX (.5 ml, unknown), unspecified dose of HIB (unknown), unspecified dose of ROTATEQ (unknown), unspecified dose of PREVNAR (unknown).  At an unspecified time after vaccination with HIB, PEDIARIX, PREVNAR and ROTATEQ, the subject experienced high fever and lethargy.  The physician reported a 4-month old subject experienced high fever and lethargy after receiving his 2nd PEDIARIX.  At the time of reporting the outcome of the events were unspecified.  The physician considered the events were possibly related to vaccination with PEDIARIX, HIB, ROTATEQ and PREVNAR.
surgery for cataract; This is a spontaneous report from a contactable consumer (patient). A 70-years-old female patient received BNT162B2 (COMIRNATY, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 2021 as dose 2, single for COVID-19 immunisation. The patient's medical history included COVID-19. she was diagnosed with covid before receiving the first two doses of the vaccine and had waited for the 90 days between her diagnosis and first dose. Reporter said she was treated with the monoclonal infusions. There were no concomitant medications. Historical vaccine included BNT162B2 (COMIRNATY, solution for injection, Lot number unknown), dose 1 via an unspecified route of administration on May2021 (at the age of 70-Years-old) as dose 1, single for COVID-19 immunisation and experienced Had no energy at all and Felt down. On an unknown date in 2021, the patient was scheduled for surgery for cataract. The reporter was planned to get her booster dose of the vaccine this month. She also had cataract surgery this month with one lens being replaced the last week in November and the other lens being replaced the first week of December. She was going to be on antibiotics and steroids. It was reported that the patient will be taking Prolensa for two weeks, Prednisolone for the whole month for both eyes, and Moxifloxacin for 9 days. Reporter would like to know if there are any interactions between the medications she will be taking for the surgery and the vaccine. It was reported that she will start Moxifloxacin 2 days before the surgery and then takes it for one week later. A friend that was on a steroid and had only one eye got her thinking about being on the steroids and COVID. Reporter clarified that the friend that had only one eye and was on steroids had nothing to do with the vaccine, but it just got her thinking. All this was unknown, and things change. She was worried about it. If they say she had to wait two or three months she will. Reporter was also informed that prednisolone was a steroid and are considered an immunosuppressant. People receiving medications that weaken the immune system (immunosuppressants) may have a lower response to Comirnaty or the Pfizer- BioNTech COVID-19 Vaccine. Reporter enquired whether she can wait to take the booster in February, two months after the surgery. With the second dose she had no problem. She exercised every day. She had a check-up every year with multiple doctors. It was reported that she doesn't have vaccination card to provide lot, and expiry. The card was locked up with her passport. It was clarified that she had not started the medications Prolensa, Prednisolone, or Moxifloxacin. At the time of this report, the outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Consumer reports that 2 wks p/son recvd 2nd immun, exp fever of 102 which was treated w/APAP; fever subsided the next day;
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 24-NOV-2014, the patient was vaccinated with an improperly stored dose of ZOSTAVAX subcutaneously, once, lot # K000326, expiration date: 24-FEB-2015 (dose was not reported). There was no adverse effects reported. Administered dose of vaccine experienced the temperature excursion of 38 degrees Fahrenheit for 40 days (reported as 40 days +) since 08-OCT-2014. This is one of several reports received from the same reporter. Additional information has been requested.
Fever, chills, achiness for 3 days followed by rash for 3 days.
Information has been received on 12-MAR-2019 from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2017, the patient was administered the ZOSTAVAX vaccine (lot # and route not specified) by a healthcare provider. On an unspecified date, the patient was treated by a physician for shingles as a result of vaccination with ZOSTAVAX. The outcome was not provided. Additional information has been requested.
pt had a positive COVID test on 1/14/22 while in nursing home asymptomatic initially except for sleeping a lot; later became congested, non-productive cough; O2 supplementation, dexamethasone, ABX and cough syrup; pt passed away in the nursing home; DC and med records sent to info@vaers.org
On 8/1/00, within 1-2 hours, post vax, the pt experienced a large local reaction in left leg, consisting of erythema and edema of the entire leg. The pt was taken back to the physician's office where he was administered Benadryl. Within 15 minutes, most of the swelling had gone down and within 30 minutes it was back to normal. The pt was also ordered Tylenol and the physician consulted with an allergist and other pediatricians. Additionally, it was noted that the pt had been pulling himself and using the leg to bear weight and was not doing so as of 8/2/00. Upon internal review, the pt's experiences were considered to be "Other Medical Events". Additional information has been requested.
Approximately 15-20 minutes after receiving immunizations patient was noted to have generalized jerking of his body & a small vomitus w/LOC for a few seconds. Patient was shaken awake & returned to baseline but appeared pale & c/o nausea. EMS was called & upon their arrival they noted that patient was pale but able to ambulate. While in the ambulance patient lost consciousness again & appeared pale. Patient's heart rate dropped into the low 30s & BP dropped to 85/42. Patient was given atropine 0.5mg @ 3:05 PM which increased his heart rate to 89 & BP to 120/58. Upon arrival @ the ED patient was alert & oriented but pale w/cyanosis of his distal extremeties. He c/o his legs trembling. Patient was given IM epi & a NS bolus @ 3:37 PM & then SOLU-MEDROL was administered. Patient was admitted to the PICU with a diagnosis of bradycardia & syncope.
Bronchitis, sinusitis, strep throat, upset stomach, burning in chest, esophageal pain, chest pain, & nausea for over 1 month. Lab work showed a dehydrating flu syndrome.
On 2/8/2023, patient presented to the emergency department via ambulance for evaluation of worsening weakness and shortness of breath. He had history of interstitial lung disease with continuous use of supplemental oxygen. Patient was given a COVID-19 NAA test which resulted positive; His chest x-ray showed a honeycomb pattern consistent with known history of interstitial pulmonary fibrosis and scattered patchy opacities consistent with COVID. Patient was treated with IV steroids, DuoNeb nebulizer, and an increase from 4L to 6L in oxygen supplementation; He was diagnosed with acute on chronic hypoxic respiratory failure, COVID-19 infection, interstitial pulmonary fibrosis exacerbation, and community acquired pneumonia. Patient was admitted to the hospital for further evaluation and treatment. During his hospital stay, the patient was placed on inpatient hospice care, and he died on 2/23/2023 at the hospital. His death abstract listed immediate cause of death as interstitial lung disease, with other significant conditions listed to be chronic diastolic congestive heart failure, COVID-19, and bacterial pneumonia.  Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital
Received Pfizer vaccines on  4/23, 5/14/21 COVID-19 positive by PCR on  1/13/22 hospitalized 1/13-1/17/22 for hydrocephalus, acute PE
Initial and follow up information has been received from a physician and a Merck Pregnancy Registry concerning an 18 year old female with a history of asthma who on 31-JAN-2007 was vaccinated intramuscularly with a 0.5 mL dose of GARDASIL, (Lot # 655205/1426F).  Concomitant therapy included albuterol.  The patient's last menstrual period was on 01-JAN-2007.  Subsequently the patient had a positive pregnancy test on 07-FEB-2007.  The patient sought unspecified medical attention.  The patient had a qualitative human chorionic gonadotropin (HCG) test.  No problems reported.  On 09-MAR-2007, the patient had an elective termination of the pregnancy.  She was approximately 9 weeks estimated gestational age (EGA).  According to the physician, the patient didn't have an elective abortion because of the vaccine.  This was an unplanned pregnancy and the patient wanted to go on to college, this was the primary reason.  The fact that she had the vaccine maybe contributed a little bit after that.  At the time of this report, the patient's outcome was unknown.  Upon internal review, elective abortion was considered an other important medical event.  Additional information is not expected.